P. Scott

发表

Enhancement of tumor growth and vascular density by transfection of vascular endothelial cell growth factor into MCF-7 human breast carcinoma cells.

A. Harris, M. Ziche, A. Harris, 1995, Journal of the National Cancer Institute.

Validation of anti‐vascular endothelial growth factor (anti‐VEGF) antibodies for immunohistochemical localization of VEGF in tissue sections: expression of VEGF in the human endometrium

A. Harris, K. Gatter, C. Lewis, 1998, The Journal of pathology.

VEGF‐B expression in human primary breast cancers is associated with lymph node metastasis but not angiogenesis

S. Fox, A. Harris, Cheng Han, 2001, The Journal of pathology.

COMMENTARY The isolation and culture of microvascular endothelium

R. Bicknell, P. Scott, 1993 .

EDITORIALS Funding health services for older people Richard

A. V. Rij, P. Joyce, B. Smaill, 2002 .

Vascular endothelial growth factor-B and vascular endothelial growth factor-C expression in renal cell carcinomas: regulation by the von Hippel-Lindau gene and hypoxia.

S. Fox, A. Harris, M. Currie, 2001, Cancer research.

Angiogenic Polypeptides in Breast Cancer: Expression of Mrna’s in Primary Human Tumours, MCF-7 Cell Transfection and Xenograft Models

A. Harris, S. Donnini, L. Morbidelli, 1998 .

The angiogenic switch for vascular endothelial growth factor (VEGF)‐A, VEGF‐B, VEGF‐C, and VEGF‐D in the adenoma–carcinoma sequence during colorectal cancer progression

Stephen B Fox, M. Currie, B. Robinson, 2003, The Journal of pathology.

The short form of the alternatively spliced flt-4 but not its ligand vascular endothelial growth factor C is related to lymph node metastasis in human breast cancers.

S. Fox, A. Harris, Cheng Han, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

Role of the hypoxia sensing system, acidity and reproductive hormones in the variability of vascular endothelial growth factor induction in human breast carcinoma cell lines

A. Harris, J. Gleadle, R. Bicknell, 1998, International journal of cancer.

Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor beta-1, platelet-derived endothelial cell growth factor, placenta growth factor, and pleiotrophin in human primary breast cancer and its relation to angiogenes

S. Fox, A. Harris, R. Leek, 1997, Cancer research.

Tumour mutational burden: an overview for pathologists.

Kenneth D. Doig, K. Doig, A. Fellowes, 2022, Pathology.

Expression of VEGF in routinely fixed material using a new monoclonal

A. Harris, K. Gatter, H. Turley, 1998, The Journal of pathology.

Breast cancer angiogenesis — new approaches to therapy via antiangiogenesis, hypoxic activated drugs, and vascular targeting

S. Fox, A. Harris, K. Gatter, 2005, Breast Cancer Research and Treatment.

The isolation and culture of microvascular endothelium.

R. Bicknell, P. Scott, 1993, Journal of cell science.

Expression of the angiopoietins and their receptor Tie2 in human renal clear cell carcinomas; regulation by the von Hippel‐Lindau gene and hypoxia

A. Harris, Cheng Han, M. Currie, 2002, The Journal of pathology.

Angiopoietin-1 is inversely related to thymidine phosphorylase expression in human breast cancer, indicating a role in vascular remodeling.

S. Fox, A. Harris, Cheng Han, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

Current approaches to targeting cancer using antiangiogenesis therapies.

A. Harris, P. Scott, P. Scott, 1994, Cancer Treatment Reviews.

Differential expression of vascular endothelial growth factor mRNA vs protein isoform expression in human breast cancer and relationship to eIF-4E.

A. Harris, R. Poulsom, A. Benedetti, 1998, British Journal of Cancer.

The 121 amino acid isoform of vascular endothelial growth factor is more strongly tumorigenic than other splice variants in vivo

R Bicknell, H. Turley, L. Morbidelli, 2000, British Journal of Cancer.